Humana CenterWell — Operating Income (Loss) decreased by 3.0% to $289.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.3%, from $392.00M to $289.00M. Over 3 years (FY 2021 to FY 2025), CenterWell — Operating Income (Loss) shows an upward trend with a 12.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher operating income indicates strong segment performance and effective management of costs and pricing.
The profit or loss generated by the CenterWell segment from its core business activities, calculated as revenue minus to...
Standard segment profitability metric; peers report this as segment operating income.
hum_segment_centerwell_operating_income_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $234.50M | $234.50M | $234.50M | $370.00M | $358.00M | $330.00M | $287.00M | $400.00M | $387.00M | $282.00M | $338.00M | $382.00M | $327.00M | $392.00M | $344.00M | $305.00M | $298.00M | $289.00M |
| QoQ Change | — | +0.0% | +0.0% | +57.8% | -3.2% | -7.8% | -13.0% | +39.4% | -3.3% | -27.1% | +19.9% | +13.0% | -14.4% | +19.9% | -12.2% | -11.3% | -2.3% | -3.0% |
| YoY Change | — | — | — | — | +52.7% | -10.8% | -19.8% | — | — | -14.5% | +17.8% | -4.5% | -15.5% | +39.0% | +1.8% | -20.2% | -8.9% | -26.3% |